Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020
Cancer Research and Treatment · 2023
DOI: 10.4143/crt.2023.447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2023. Verfasst von Mee Joo Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Korea Central Cancer Registry, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 206-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Health and Welfare, National Cancer Center.
Abstract (Originalsprache)
Purpose
The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2020.Materials and Methods Incidence, survival, and prevalence rates of cancer were calculated using the Korea National Cancer Incidence Database, from 1999 to 2020, with survival follow-up until December 31, 2021. Deaths from cancer were assessed using causes-of-death data obtained from Statistics Korea.
Results
The number of new cancer diagnoses in 2020 decreased by 9,218 cases (3.6%) compared to 2019. In 2020, newly diagnosed cancer cases and deaths from cancer were reported as 247,952 (age-standardized rate [ASR], 262.2 per 100,000) and 82,204 (ASR, 69.9 per 100,000), respectively. The overall cancer incidence rates increased by 3.3% annually from 1999 to 2012, and decreased by 5.0% annually from 2012 to 2015, thereafter, followed by nonsignificant changes. Cancer mortality rates have been decreasing since 2002, with more rapid decline in recent years. The 5-year relative survival between 2016 and 2020 was 71.5%, which contributed to prevalent cases reaching over 2.2 million in 2020.
Conclusion
In 2020, the number of newly diagnosed cancer patients decreased due to the coronavirus disease 2019 pandemic, but the overall trend is on the rise. Cancer survival rates have improved over the past decades. As the number of cancer survivors increases, a comprehensive cancer control strategy should be implemented in line with the changing aspects of cancer statistics. The long-term impact of the coronavirus disease 2019 pandemic on cancer statistics needs to be investigated in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Korea Central Cancer Registry, National Cancer Center, Goyang, Korea.
- Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
- National Cancer Control Institute, National Cancer Center, Goyang, Korea.
- National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Förderung
- Ministry of Health and Welfare
- National Cancer Center
Zitieren
APA
Kang, M. J., Jung, K. W., Bang, S. H., Choi, S. H., Park, E. H., Yun, E. H., Kim, H. J., Kong, H. J., Im, J. S., Seo, H. G., & Community of Population-Based Regional Cancer Registries* (2023). Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020. Cancer Research and Treatment. https://doi.org/10.4143/crt.2023.447
Vancouver
Kang MJ, Jung KW, Bang SH, Choi SH, Park EH, Yun EH, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020. Cancer Research and Treatment. 2023. doi:10.4143/crt.2023.447
BibTeX
@article{Kang2023,
author = {Kang, Mee Joo and Jung, Kyu-Won and Bang, So Hyun and Choi, Seo Hyun and Park, Eun Hye and Yun, E Hwa and Kim, Hye-Jin and Kong, Hyun-Joo and Im, Jeong-Soo and Seo, Hong Gwan and Community of Population-Based Regional Cancer Registries*, Community of Population-Based Regional Cancer Registries*},
title = {Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020},
journal = {Cancer Research and Treatment},
year = {2023},
doi = {10.4143/crt.2023.447}
}
EUVIMED